BMO Capital Starts NewAmsterdam Pharma Co NV (NAMS) at Outperform
Tweet
Share
E-mailGet Alerts NAMS Hot Sheet
Price: $27.87 +0.32%
Rating Summary:
16 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
16 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
BMO Capital initiates coverage on NewAmsterdam Pharma Co NV (NASDAQ: NAMS) with a Outperform rating and a price target of $58.00.
For an analyst ratings summary and ratings history on NewAmsterdam Pharma Co NV click here. For more ratings news on NewAmsterdam Pharma Co NV click here.
Shares of NewAmsterdam Pharma Co NV closed at $31.68 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Starts AMD (AMD) at Outperform
- Alzamend Neuro (ALZN) files for 98.4M share offering by selling stockholders
- Solowin Holdings marks 10 years, expands into stablecoins and AI
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
BMO Capital, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
